Human immune response towards recombinant Helicobacter pylori urease and cellular fractions

Vaccine

Volumn 24, Issue 18, 2006, Pages 3832-3839

  Voland, Petra ^a   Zeitner, Marco ^a   Hafsi, Nadia ^a   Prinz, Christian ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cellular fractions; Helicobacter pylori; Urease A and B

Indexed keywords

ALLOANTIGEN; CD45RA ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HELICOBACTER PYLORI VACCINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; OUTER MEMBRANE PROTEIN; RECOMBINANT ENZYME; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UREASE; UREASE A; UREASE B;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL OUTER MEMBRANE; CELL CULTURE; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL ISOLATION; CELL POLARITY; CELL SEPARATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; CYTOSOL; DENDRITIC CELL; DRUG EFFICACY; DRUG POTENCY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; MONOCYTE; NATURAL KILLER T CELL; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; TH1 CELL; VACCINATION; VOLUNTEER;

BACTERIAL VACCINES; CELL MEMBRANE; CELLS, CULTURED; CYTOKINES; CYTOSOL; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HELICOBACTER PYLORI; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA; UREASE; VACCINES, SYNTHETIC;

EID: 33646471232     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.07.021     Document Type: Article

References (40)

1. Covacci A., Telford J.L., Del G.G., Parsonnet J., and Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 284 (1999) 1328-1333
2. Michetti P., Kreiss C., Kotloff K.L., Porta N., Blanco J.L., Bachmann D., et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 116 (1999) 804-812
3. Ermak T.H., Giannasca P.J., Nichols R., Myers G.A., Nedrud J., Weltzin R., et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 188 (1998) 2277-2288
4. Kimmel B., Bosserhoff A., Frank R., Gross R., Goebel W., and Beier D. Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies. Infect Immun 68 (2000) 915-920
5. Haas G., Karaali G., Ebermayer K., Metzger W.G., Lamer S., Zimny-Arndt U., et al. Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics 2 (2002) 313-324
6. Voland P., Weeks D.L., Vaira D., Prinz C., and Sachs G. Specific identification of three low molecular weight membrane-associated antigens of Helicobacter pylori. Aliment Pharmacol Ther 16 (2002) 533-544
7. Alm R.A., Bina J., Andrews B.M., Doig P., Hancock R.E., and Trust T.J. Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families. Infect Immun 68 (2000) 4155-4168
8. Keenan J., Day T., Neal S., Cook B., Perez-Perez G., Allardyce R., et al. A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection. FEMS Microbiol Lett 182 (2000) 259-264
9. Rescigno M., Granucci F., Citterio S., Foti M., and Ricciardi-Castagnoli P. Coordinated events during bacteria-induced DC maturation. Immunol Today 20 (1999) 200-203
10. Hafsi N., Voland P., Schwendy S., Rad R., Reindl W., Gerhard M., et al. Human dendritic cells respond to Helicobacter pylori, promoting NK cell and Th1-effector responses in vitro. J Immunol 173 (2004) 1249-1257
11. D'Elios M.M., Manghetti M., De Carli M., Costa F., Baldari C.T., Burroni D., et al. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 158 (1997) 962-967
12. Prinz C., Hafsi N., and Voland P. Helicobacter pylori virulence factors and the host immune response: implications for therapeutic vaccination. Trends Microbiol 11 (2003) 134-138
13. Liu S., Tobias R., McClure S., Styba G., Shi Q., and Jackowski G. Removal of endotoxin from recombinant protein preparations. Clin Biochem 30 (1997) 455-463
14. Del Giudice G., Covacci A., Telford J.L., Montecucco C., and Rappuoli R. The design of vaccines against Helicobacter pylori and their development. Annu Rev Immunol 19 (2001) 523-563
15. Blanchard T.G., Eisenberg J.C., and Matsumoto Y. Clearance of Helicobacter pylori infection through immunization: the site of T cell activation contributes to vaccine efficacy. VACCINE 22 (2004) 888-897
16. Smythies L.E., Waites K.B., Lindsey J.R., Harris P.R., Ghiara P., and Smith P.D. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol 165 (2000) 1022-1029
17. Fan X., Crowe S.E., Behar S., Gunasena H., Ye G., Haeberle H., et al. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1-mediated damage. J Exp Med 187 (1998) 1659-1669
18. Haeberle H.A., Kubin M., Bamford K.B., Garofalo R., Graham D.Y., El Zaatari F., et al. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect Immun 65 (1997) 4229-4235
19. Ernst P.B., and Pappo J. Preventive and therapeutic vaccines against Helicobacter pylori: current status and future challenges. Curr Pharm Des 6 (2000) 1557-1573
20. Wang J., Fan X., Lindholm C., Bennett M., O'Connoll J., Shanahan F., et al. Helicobacter pylori modulates lymphoepithelial cell interactions leading to epithelial cell damage through Fas/Fas ligand interactions. Infect Immun 68 (2000) 4303-4311
21. Mobley H.L. The role of Helicobacter pylori urease in the pathogenesis of gastritis and peptic ulceration. Aliment Pharmacol Ther 10 Suppl. 1 (1996) 57-64
22. Weeks D.L., Eskandari S., Scott D.R., and Sachs G. A H+-gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science 287 5452 (2000) 482-485
23. Bury-Mone S., Skouloubris S., Labigne A., and De Reuse H. The Helicobacter pylori UreI protein: role in adaptation to acidity and identification of residues essential for its activity and for acid activation. Mol Microbiol 42 (2001) 1021-1034
24. Oleksowicz L., and Dutcher J.P. A Review of the New Cytokines: IL-4, IL-6, IL-11, and IL-12. Am J Ther 1 (1994) 107-115
25. Straubinger R.K., Greiter A., McDonough S.P., Gerold A., Scanziani E., Soldati S., et al. Quantitative evaluation of inflammatory and immune responses in the early stages of chronic Helicobacter pylori infection. Infect Immun 71 (2003) 2693-2703
26. Yamaoka Y., Kita M., Kodama T., Sawai N., Tanahashi T., Kashima K., et al. Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut 42 (1998 May) 609-617
27. Rad R., Gerhard M., Lang R., Schoniger M., Rosch T., Schepp W., et al. The Helicobacter pylori blood group antigen-binding adhesin facilitates bacterial colonization and augments a nonspecific immune response. J Immunol 168 (2002) 3033-3041
28. Karttunen R.A., Karttunen T.J., Yousfi M.M., el Zimaity H.M., Graham D.Y., and el Zaatari F.A. Expression of mRNA for interferon-gamma, interleukin-10, and interleukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pylori. Scand J Gastroenterol 32 (1997) 22-27
29. Ernst P.B., and Gold B.D. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 54 (2000) 615-640
30. Bodger K., and Crabtree J.E. Helicobacter pylori and gastric inflammation. Br Med Bull 54 (1998) 139-150
31. Crabtree J.E. Immune and inflammatory responses to Helicobacter pylori infection. Scand J Gastroenterol Suppl 215 (1996) 3-10
32. Tarkkanen J., Kosunen T.U., and Saksela E. Contact of lymphocytes with Helicobacter pylori augments natural killer cell activity and induces production of gamma interferon. Infect Immun 61 (1993) 3012-3016
33. Soloski M.J. Recognition of tumor cells by the innate immune system. Curr Opin Immunol 13 (2001) 154-162
34. Mohammadi M., Czinn S., Redline R., and Nedrud J. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J Immunol 156 (1996) 4729-4738
35. Kidane A., Guimond P., Ju T.R., Sanchez M., Gibson J., and Bowersock T.L. The efficacy of oral vaccination of mice with alginate encapsulated outer membrane proteins of Pasteurella haemolytica and One-Shot. VACCINE 19 (2001) 2637-2646
36. Murphy T.F., Kirkham C., Liu D.F., and Sethi S. Human immune response to outer membrane protein CD of Moraxella catarrhalis in adults with chronic obstructive pulmonary disease. Infect Immun 71 (2003) 1288-1294
37. Milagres L.G., Gorla M.C., Rebelo M.C., and Barroso D.E. Bactericidal antibody response to Neisseria meningitidis serogroup B in patients with bacterial meningitis: effect of immunization with an outer membrane protein vaccine. FEMS Immunol Med Microbiol 28 (2000) 319-327
38. Langermann S., and Ballou W.R. Development of a recombinant FimCH vaccine for urinary tract infections. Adv Exp Med Biol 539 (2003) 635-648
39. Langermann S., and Ballou Jr. W.R. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections. J Infect Dis 183 Suppl. 1 (2001) S84-S86
40. Smith Jr. M.F., Mitchell A., Li G., Ding S., Fitzmaurice A.M., Ryan K., et al. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 278 (2003) 32552-32560